No Data
No Data
No Data
No Data
No Data
Investors Interested In Qiagen N.V.'s (NYSE:QGEN) Earnings
Qiagen N.V.'s (NYSE:QGEN) price-to-earnings (or "P/E") ratio of 26.9x might make it look like a strong sell right now compared to the market in the United States, where around half of the companies ha
Simply Wall StApr 25 07:08 ET
QIAGEN Expands Tuberculosis Portfolio With New NGS Panel To Support Real-Time Surveillance And Combat Antimicrobial Resistance
QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA))))) today announced the launch of the QIAseq xHYB Mycobacterium tuberculosis Panel for research use, a new tool in the fight against tuberculosis (TB)
BenzingaApr 24 16:50 ET
Top Gap Ups and Downs on Monday: TSLA, HSBC, SE and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
moomoo NewsApr 22 19:36 ET
Express News | NYSE Order Imbalance 52778.0 Shares on Sell Side
Moomoo 24/7Apr 22 15:50 ET
Bank of America Securities Reaffirms Their Buy Rating on Qiagen (QGEN)
TipRanksApr 17 10:35 ET
QIAGEN N.V. to Release Results for Q1 2024 and Hold Webcast
Venlo, The Netherlands, April 09, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the first quarter 2024. Press release date
GlobeNewswireApr 9 09:48 ET
No Data
No Data